Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review

Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review

Bibliographic Details
Main Author:	Editorial Article
Format:	Article
Language:	Russian
Published:	Numikom LLC 2017-08-01
Series:	Эпидемиология и вакцинопрофилактика
Online Access:	https://www.epidemvac.ru/jour/article/view/309

Similar Items

Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents
by: L.P. Zanaga, et al.

Review: Hepatitis C virus replication and potential targets for direct-acting agents
by: Jacqueline G. O'Leary, et al.
Published: (2010-01-01)

SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection
by: Abdullah S Alghamdi, et al.
Published: (2015-01-01)

Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in Pakistan
by: Saba Khaliq, et al.
Published: (2018-11-01)

Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents
by: LI Junli
Published: (2018-02-01)

Review: New direct-acting antivirals in the development for hepatitis C virus infection
by: Paul J. Pockros
Published: (2010-05-01)

Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents
by: YU Yuecheng
Published: (2018-02-01)

Current research on hepatitis C virus resistance to direct-acting antiviral agents
by: REN Shan, et al.
Published: (2015-11-01)

Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis
by: Kamolyut Lapumnuaypol, et al.
Published: (2020-01-01)

New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents
by: Josep Quer, et al.
Published: (2010-11-01)

A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral Agents
by: Barbara de M. Quintela, et al.
Published: (2018-04-01)

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.
by: Fei Xiao, et al.
Published: (2014-05-01)

Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients
by: Soraya Abad, et al.
Published: (2017-03-01)

Newer direct-acting antivirals for hepatitis C virus infection: Perspectives for India
by: Varun Gupta, et al.
Published: (2017-01-01)

Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis
by: Leonardo Frazzoni, et al.
Published: (2021-04-01)

Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience
by: Gianfranco Lauletta, et al.
Published: (2017-04-01)

Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis
by: Michael J. Zoratti, et al.
Published: (2020-01-01)

Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus Infection
by: Yi-Ling Ko, et al.
Published: (2018-11-01)

Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
by: Rita Calça, et al.
Published: (2020-11-01)

Hepatocellular carcinoma after direct-acting antiviral therapy in kidney transplant recipients infected with hepatitis C virus
by: Rita Calça, et al.
Published: (2020-11-01)

A nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis C virus infection
by: Steffanie Nario, et al.
Published: (2021-06-01)

Lupus-Like Immune Complex-Mediated Glomerulonephritis in Patients With Hepatitis C Virus Infection Treated With Oral, Interferon-Free, Direct-Acting Antiviral Therapy
by: Meghan E. Sise, et al.
Published: (2016-09-01)

Comparing the Efficacy of Direct Acting Antiviral Agents for the Treatment of Hepatitis C Virus Genotype 1
by: Ali, Rahma, et al.
Published: (2016)

Treatment of chronic viral hepatitis C with direct acting antiviral agent: review
by: V A Malov, et al.
Published: (2019-11-01)

Hepatitis C virus-associated membranoproliferative glomerulonephritis treated with directly acting antiviral therapy
by: S Nayak, et al.
Published: (2018-01-01)

Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents
by: Minosse C, et al.
Published: (2018-11-01)

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus
by: Tavares RCF, et al.
Published: (2018-10-01)

Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders
by: Heidar Sharafi, et al.
Published: (2021-10-01)

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
by: Claudia Westermann, et al.
Published: (2018-05-01)

Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents
by: Kamal SM
Published: (2014-06-01)

Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience
by: Mohamad M. Alkadi, et al.
Published: (2021-03-01)

Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany
by: Melanie Runge, et al.
Published: (2020-01-01)

Resolution of refractory hepatic hydrothorax in patients with hepatitis C virus cirrhosis after treatment with direct-acting antiviral agents
by: Maged H Hussein, et al.
Published: (2018-01-01)

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma
by: Yumiko Nagao, et al.
Published: (2017-11-01)

Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection
by: Yong-yu Mei, et al.
Published: (2020-01-01)

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]
by: Tavares RCF, et al.
Published: (2018-12-01)

Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis
by: Haruna Yamamoto, et al.
Published: (2018-07-01)

Direct-acting antiviral agents in Hepatitis C Virus-infected renal allograft recipients: Treatment and outcome experience from single center
by: N Prasad, et al.
Published: (2018-01-01)

Hepatitis C Virus Infection Among Reproductive Aged Women and Children in the United States
by: Editorial Article
Published: (2017-08-01)

Budget Impact Analysis of Novel Direct-Acting Antivirals For Hepatitis C Virus Infection in Taiwan
by: Wan-Jung Kuo, et al.
Published: (2019)